好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2016 Annual Meeting | Improving Accuracy of Dementia Diagnosis: Case Studies with Both Imaging and Neuropathology

Tuesday 04/19/16
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Edward Y. Zamrini, MD
General Neurology
Participants should be able to appreciate the differences in diagnostic criteria for the major neurodegenerative diseases, become familiar with key distinguishing features, recognize when to use certain tests to increase diagnostic confidence, and appreciate the importance of neuropathological confirmation.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic, Interactive, Audience Participation
Event Timeline
01:00 PM - 01:10 PM Introduction and Process
Edward Y. Zamrini, MD
01:10 PM - 03:00 PM Cases, Audience Response, and Discussions
James B. Leverenz, MD, FAAN, Edward Y. Zamrini, MD
Faculty Disclosures
Edward Y. Zamrini, MD Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH.
James B. Leverenz, MD, FAAN Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.